Geisbert JB - Search Results

1

The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms.

Cross RW, Wiethoff CM, Brown-Augsburger P, Berens S, Blackbourne J, Liu L, Wu X, Tetreault J, Dodd C, Sina R, Witcher DR, Newcomb D, Frost D, Wilcox A, Borisevich V, Agans KN, Woolsey C, Prasad AN, Deer DJ, Geisbert JB, Dobias NS, Fenton KA, Strifler B, Ebert P, Higgs R, Beall A, Chanda S, Riva L, Yin X, Geisbert TW. Cross RW, et al. Among authors: geisbert jb. Pathogens. 2023 Nov 30;12(12):1408. doi: 10.3390/pathogens12121408. Pathogens. 2023. PMID: 38133292 Free PMC article.

2

Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.

Pushko P, Geisbert J, Parker M, Jahrling P, Smith J. Pushko P, et al. J Virol. 2001 Dec;75(23):11677-85. doi: 10.1128/JVI.75.23.11677-11685.2001. J Virol. 2001. PMID: 11689649 Free PMC article.

3

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants.

Hevey M, Negley D, Geisbert J, Jahrling P, Schmaljohn A. Hevey M, et al. Virology. 1997 Dec 8;239(1):206-16. doi: 10.1006/viro.1997.8883. Virology. 1997. PMID: 9426460 Free article.

4

Marburg virus vaccines: comparing classical and new approaches.

Hevey M, Negley D, VanderZanden L, Tammariello RF, Geisbert J, Schmaljohn C, Smith JF, Jahrling PB, Schmaljohn AL. Hevey M, et al. Vaccine. 2001 Nov 12;20(3-4):586-93. doi: 10.1016/s0264-410x(01)00353-x. Vaccine. 2001. PMID: 11672925

5

Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.

Geisbert TW, Hensley LE, Geisbert JB, Jahrling PB. Geisbert TW, et al. Among authors: geisbert jb. Virology. 2002 Feb 1;293(1):15-9. doi: 10.1006/viro.2001.1279. Virology. 2002. PMID: 11853394 Free article.

6

Effective post-exposure treatment of Ebola infection.

Feldmann H, Jones SM, Daddario-DiCaprio KM, Geisbert JB, Ströher U, Grolla A, Bray M, Fritz EA, Fernando L, Feldmann F, Hensley LE, Geisbert TW. Feldmann H, et al. Among authors: geisbert jb, geisbert tw. PLoS Pathog. 2007 Jan;3(1):e2. doi: 10.1371/journal.ppat.0030002. PLoS Pathog. 2007. PMID: 17238284 Free PMC article. Clinical Trial.

7

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys.

Oswald WB, Geisbert TW, Davis KJ, Geisbert JB, Sullivan NJ, Jahrling PB, Parren PW, Burton DR. Oswald WB, et al. Among authors: geisbert jb, geisbert tw. PLoS Pathog. 2007 Jan;3(1):e9. doi: 10.1371/journal.ppat.0030009. PLoS Pathog. 2007. PMID: 17238286 Free PMC article. Clinical Trial.

8

Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.

Larsen T, Stevens EL, Davis KJ, Geisbert JB, Daddario-DiCaprio KM, Jahrling PB, Hensley LE, Geisbert TW. Larsen T, et al. Among authors: geisbert jb, geisbert tw. J Infect Dis. 2007 Nov 15;196 Suppl 2:S323-8. doi: 10.1086/520589. J Infect Dis. 2007. PMID: 17940967

9

Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.

Jahrling PB, Geisbert JB, Swearengen JR, Larsen T, Geisbert TW. Jahrling PB, et al. Among authors: geisbert jb, geisbert tw. J Infect Dis. 2007 Nov 15;196 Suppl 2:S400-3. doi: 10.1086/520587. J Infect Dis. 2007. PMID: 17940976

10

Cellular immune response to Marburg virus infection in cynomolgus macaques.

Fritz EA, Geisbert JB, Geisbert TW, Hensley LE, Reed DS. Fritz EA, et al. Among authors: geisbert jb, geisbert tw. Viral Immunol. 2008 Sep;21(3):355-63. doi: 10.1089/vim.2008.0023. Viral Immunol. 2008. PMID: 18788943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page